Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping Meeting Abstract


Authors: Yang, J. C. H.; Ahn, M. J.; Sakai, H.; Morise, M.; Kato, T.; Chen, Y. M.; Han, J. Y.; Yang, J. J.; Zhao, J.; Huang, J.; Berghoff, K.; Bruns, R.; Otto, G.; Le, X.; Paik, P.
Abstract Title: Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping
Meeting Title: European Lung Cancer Congress (ELCC) 2022
Journal Title: Annals of Oncology
Volume: 33
Issue: Suppl. 2
Meeting Dates: 2022 Mar 30-Apr 2
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2022-04-01
Start Page: S41
End Page: S42
Language: English
ACCESSION: WOS:000778453100026
DOI: 10.1016/j.annonc.2022.02.034
PROVIDER: wos
Notes: Meeting Abstract: 25P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    255 Paik